Horizon scanning (HS) is a research process aimed at determining the areas with the greatest potential for the analyzed drug in the Polish health care system (based on the available and often very preliminary clinical data). The HS analysis also strives to define the role of the drug in the therapeutic areas of unmet clinical needs.
Horizon scanning analysis may include:
- market situation analysis and forecast of changes,
- available clinical data (published in the form of full-text, abstracts, news)
- available guidelines and recommendations and their analysis,
- pre-selection of comparators and direction to prepare a HTA report.
Horizon scanning makes it possible to choose the optimal pre-marketing actions, directions and to plan the reimbursement strategy.